{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:56:43Z","timestamp":1791475003859,"version":"4.3.4"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1001\/jamainternmed.2020.0193","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T15:31:03Z","timestamp":1583767863000},"page":"718","source":"Crossref","is-referenced-by-count":180,"title":["Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate"],"prefix":"10.1001","volume":"180","author":[{"given":"Yao","family":"Qiao","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Im","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa K.","family":"Chen","sequence":"additional","affiliation":[{"name":"Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland"},{"name":"Division of Nephrology, Department of Internal Medicine, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Inker","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Caleb","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R.","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Geisinger Health System, Danville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland"},{"name":"Division of Nephrology, Department of Internal Medicine, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"21","key":"ioi200009r1","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"issue":"12","key":"ioi200009r2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"issue":"10","key":"ioi200009r3","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1097\/00004872-200110000-00023","article-title":"A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease.","volume":"19","author":"Marin","year":"2001","journal-title":"J Hypertens"},{"issue":"19","key":"ioi200009r4","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"ioi200009r5","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.recesp.2016.10.014","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.","volume":"69","author":"Ponikowski","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"4","key":"ioi200009r6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10557-010-6244-x","article-title":"Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.","volume":"24","author":"Ferrari","year":"2010","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"ioi200009r7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000013599","article-title":"Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors.","volume":"20","author":"Ahuja","year":"2000","journal-title":"Am J Nephrol"},{"issue":"11","key":"ioi200009r8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078465","article-title":"ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study.","volume":"8","author":"Tomlinson","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"ioi200009r9","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1016\/j.mayocp.2019.05.031","article-title":"Discontinuation of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.","volume":"94","author":"Qiao","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"ioi200009r10","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1111\/bcp.v84.10","article-title":"Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: a UK population-based study.","volume":"84","author":"Mahmoudpour","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"ioi200009r12","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1093\/ndt\/gfp511","article-title":"The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.","volume":"25","author":"Ahmed","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"ioi200009r13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1056\/NEJMoa053107","article-title":"Efficacy and safety of benazepril for advanced chronic renal insufficiency.","volume":"354","author":"Hou","year":"2006","journal-title":"N Engl J Med"},{"issue":"12","key":"ioi200009r14","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1097\/01.ASN.0000146423.71226.0C","article-title":"Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results.","volume":"15","author":"Remuzzi","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"ioi200009r15","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1681\/ASN.V12122832","article-title":"ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results.","volume":"12","author":"Ruggenenti","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"ioi200009r16","first-page":"255","article-title":"Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial.","volume":"31","author":"Bhandari","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"ioi200009r17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","article-title":"Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency.","volume":"75","author":"Levey","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"ioi200009r18","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.2215\/CJN.13811217","article-title":"Risks and benefits of direct oral anticoagulants across the spectrum of GFR among incident and prevalent patients with atrial fibrillation.","volume":"13","author":"Shin","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"13","key":"ioi200009r19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011822","article-title":"Hidden burden of electronic health record-identified familial hypercholesterolemia: clinical outcomes and cost of medical care.","volume":"8","author":"Patel","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"ioi200009r20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"1","key":"ioi200009r21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2307\/2533160","article-title":"Matching using estimated propensity scores: relating theory to practice.","volume":"52","author":"Rubin","year":"1996","journal-title":"Biometrics"},{"issue":"25","key":"ioi200009r22","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"446","key":"ioi200009r23","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"ioi200009r24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jamaoncol.2017.2752","article-title":"Examining bias in studies of statin treatment and survival in patients with cancer.","volume":"4","author":"Emilsson","year":"2018","journal-title":"JAMA Oncol"},{"issue":"6","key":"ioi200009r25","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1093\/ije\/dyv295","article-title":"Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy.","volume":"45","author":"Cain","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"4","key":"ioi200009r26","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/biomet\/85.4.907","article-title":"Dual and simultaneous sensitivity analysis for matched pairs.","volume":"85","author":"Gastwirth","year":"1998","journal-title":"Biometrika"},{"issue":"6","key":"ioi200009r27","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s11121-012-0339-5","article-title":"An introduction to sensitivity analysis for unobserved confounding in nonexperimental prevention research.","volume":"14","author":"Liu","year":"2013","journal-title":"Prev Sci"},{"issue":"5","key":"ioi200009r28","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","article-title":"Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a bayesian network meta-analysis of randomized clinical trials.","volume":"67","author":"Xie","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"ioi200009r29","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jacc.2013.10.050","article-title":"Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease.","volume":"63","author":"Molnar","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"ioi200009r30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/2229-3485.83221","article-title":"Intention-to-treat concept: a review.","volume":"2","author":"Gupta","year":"2011","journal-title":"Perspect Clin Res"},{"key":"ioi200009r11","unstructured":"National Kidney Foundation. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. 2013.https:\/\/kdigo.org\/wp-content\/uploads\/2017\/02\/KDIGO_2012_CKD_GL.pdf. Accessed July 26, 2018."}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2762699\/jamainternal_qiao_2020_oi_200009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T01:41:35Z","timestamp":1666057295000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2762699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2020.0193","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}